Todd R. Palmby

3.7k total citations
19 papers, 1.6k citations indexed

About

Todd R. Palmby is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Todd R. Palmby has authored 19 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Todd R. Palmby's work include Protein Kinase Regulation and GTPase Signaling (4 papers), HER2/EGFR in Cancer Research (4 papers) and Advanced Breast Cancer Therapies (3 papers). Todd R. Palmby is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (4 papers), HER2/EGFR in Cancer Research (4 papers) and Advanced Breast Cancer Therapies (3 papers). Todd R. Palmby collaborates with scholars based in United States and France. Todd R. Palmby's co-authors include Richard Pazdur, Channing J. Der, Julie Gavard, Panomwat Amornphimoltham, Rajeshwari Sridhara, Yi Zheng, Wenfu Tan, Shenghui Tang, Antoine E. Karnoub and Ernst Lengyel and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular and Cellular Biology.

In The Last Decade

Todd R. Palmby

19 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Todd R. Palmby United States 18 927 541 355 225 179 19 1.6k
Maria Sundvall Finland 20 1.2k 1.3× 949 1.8× 303 0.9× 120 0.5× 289 1.6× 33 1.8k
Randall Schreck United States 9 1.5k 1.6× 686 1.3× 318 0.9× 150 0.7× 469 2.6× 13 2.3k
Nandini Dey United States 25 1.4k 1.6× 907 1.7× 365 1.0× 147 0.7× 432 2.4× 71 2.1k
Rajani Kanteti United States 21 761 0.8× 513 0.9× 446 1.3× 135 0.6× 219 1.2× 40 1.4k
Nila U. Parikh United States 26 1.5k 1.6× 1.2k 2.3× 314 0.9× 245 1.1× 522 2.9× 39 2.5k
Paul J. Adam Austria 15 952 1.0× 442 0.8× 145 0.4× 158 0.7× 210 1.2× 23 1.5k
T. Annie T. Fong United States 7 1.3k 1.4× 523 1.0× 231 0.7× 115 0.5× 555 3.1× 10 1.8k
Tim P. Green United Kingdom 13 699 0.8× 504 0.9× 159 0.4× 95 0.4× 133 0.7× 14 1.2k
Maria Niewolna United States 18 1.0k 1.1× 1.2k 2.2× 351 1.0× 115 0.5× 304 1.7× 23 2.0k
Babita Saigal United States 15 723 0.8× 460 0.9× 288 0.8× 87 0.4× 175 1.0× 26 1.2k

Countries citing papers authored by Todd R. Palmby

Since Specialization
Citations

This map shows the geographic impact of Todd R. Palmby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd R. Palmby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd R. Palmby more than expected).

Fields of papers citing papers by Todd R. Palmby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd R. Palmby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd R. Palmby. The network helps show where Todd R. Palmby may publish in the future.

Co-authorship network of co-authors of Todd R. Palmby

This figure shows the co-authorship network connecting the top 25 collaborators of Todd R. Palmby. A scholar is included among the top collaborators of Todd R. Palmby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd R. Palmby. Todd R. Palmby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gong, Xiajing, Meng Hu, Jinzhong Liu, et al.. (2022). Decoding kinase-adverse event associations for small molecule kinase inhibitors. Nature Communications. 13(1). 4349–4349. 13 indexed citations
2.
Shah, Anand, Erik Bloomquist, Shenghui Tang, et al.. (2018). FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Advanced or Metastatic Breast Cancer. Clinical Cancer Research. 24(13). 2999–3004. 88 indexed citations
3.
Singh, Harpreet, Amanda J. Walker, Laleh Amiri‐Kordestani, et al.. (2018). U.S. Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer. Clinical Cancer Research. 24(15). 3486–3491. 75 indexed citations
4.
Ning, Yang‐Min, Daniel L. Suzman, V. Ellen Maher, et al.. (2017). FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum-Containing Chemotherapy. The Oncologist. 22(6). 743–749. 112 indexed citations
5.
Sheng, Calvin C., Laleh Amiri‐Kordestani, Todd R. Palmby, et al.. (2016). 21st Century Cardio-Oncology. JACC Basic to Translational Science. 1(5). 386–398. 33 indexed citations
6.
Walker, Amanda J., Suparna Wedam, Laleh Amiri‐Kordestani, et al.. (2016). FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer. Clinical Cancer Research. 22(20). 4968–4972. 104 indexed citations
7.
Axelson, Michael D., Ke Liu, Xiaoping Jiang, et al.. (2013). U.S. Food and Drug Administration Approval: Vismodegib for Recurrent, Locally Advanced, or Metastatic Basal Cell Carcinoma. Clinical Cancer Research. 19(9). 2289–2293. 140 indexed citations
8.
Mikelis, Constantinos M., Todd R. Palmby, May Simaan, et al.. (2013). PDZ-RhoGEF and LARG Are Essential for Embryonic Development and Provide a Link between Thrombin and LPA Receptors and Rho Activation. Journal of Biological Chemistry. 288(17). 12232–12243. 52 indexed citations
9.
Kluetz, Paul G., Yang‐Min Ning, V. Ellen Maher, et al.. (2013). Abiraterone Acetate in Combination with Prednisone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer: U.S. Food and Drug Administration Drug Approval Summary. Clinical Cancer Research. 19(24). 6650–6656. 49 indexed citations
10.
Kluetz, Paul G., William F. Pierce, V. Ellen Maher, et al.. (2013). Radium Ra 223 Dichloride Injection: U.S. Food and Drug Administration Drug Approval Summary. Clinical Cancer Research. 20(1). 9–14. 125 indexed citations
11.
Herndon, Thomas M., Albert Deisseroth, Edvardas Kaminskas, et al.. (2013). U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma. Clinical Cancer Research. 19(17). 4559–4563. 198 indexed citations
12.
Ning, Yang‐Min, William F. Pierce, V. Ellen Maher, et al.. (2013). Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Previously Received Docetaxel: U.S. Food and Drug Administration Drug Approval Summary. Clinical Cancer Research. 19(22). 6067–6073. 39 indexed citations
13.
Sakurai, Atsuko, Julie Gavard, John R. Basile, et al.. (2010). Semaphorin 3E Initiates Antiangiogenic Signaling through Plexin D1 by Regulating Arf6 and R-Ras. Molecular and Cellular Biology. 30(12). 3086–3098. 131 indexed citations
14.
Tan, Wenfu, et al.. (2008). An essential role for Rac1 in endothelial cell function and vascular development. The FASEB Journal. 22(6). 1829–1838. 185 indexed citations
15.
Wolf, Joshua H., Todd R. Palmby, Julie Gavard, Bart O. Williams, & J. Silvio Gutkind. (2007). Multiple PPPS/TP motifs act in a combinatorial fashion to transduce Wnt signaling through LRP6. FEBS Letters. 582(2). 255–261. 28 indexed citations
16.
Palmby, Todd R., Karon Abe, Antoine E. Karnoub, & Channing J. Der. (2004). Vav Transformation Requires Activation of Multiple GTPases and Regulation of Gene Expression. Molecular Cancer Research. 2(12). 702–711. 20 indexed citations
17.
Singh, Anurag, Antoine E. Karnoub, Todd R. Palmby, et al.. (2004). Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation. Oncogene. 23(58). 9369–9380. 147 indexed citations
18.
Palmby, Todd R., Karon Abe, & Channing J. Der. (2002). Critical Role of the Pleckstrin Homology and Cysteine-rich Domains in Vav Signaling and Transforming Activity. Journal of Biological Chemistry. 277(42). 39350–39359. 23 indexed citations
19.
Palmby, Todd R., et al.. (2002). Cellular N-Ras Promotes Cell Survival by Downregulation of Jun N-Terminal Protein Kinase and p38. Molecular and Cellular Biology. 22(5). 1589–1606. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Sundvall Breakdown of academic impact, for papers by Randall Schreck Breakdown of academic impact, for papers by Nandini Dey Breakdown of academic impact, for papers by Rajani Kanteti Breakdown of academic impact, for papers by Nila U. Parikh Breakdown of academic impact, for papers by Paul J. Adam Breakdown of academic impact, for papers by T. Annie T. Fong Breakdown of academic impact, for papers by Tim P. Green Breakdown of academic impact, for papers by Maria Niewolna Breakdown of academic impact, for papers by Babita Saigal
Rankless by CCL
2026